Benitec Biopharma Inc. (BNTC:NASDAQ) jumped higher at $3.2, representing a gain of 65.8%. On Wed, Aug 09, 2023, BNTC:NASDAQ touched a New 2-Week Intraday High of $4.84. The stock appeared on our News Catalysts scanner on Wed, Aug 09, 2023 at 03:01 AM in the 'PUBLIC OFFERING' category. From Wed, Jul 26, 2023, the stock recorded 10.00% Up Days and 18.18% Green Days
The stock spiked on Wed, Aug 09, 2023 at $4.84 with a volume of 25M+.
About Benitec Biopharma Inc. (BNTC:NASDAQ)
Benitec Biopharma Ltd is a biotechnology company which develops therapeutic technology platform that combines gene silencing and gene therapy which cures disease causing genes from single administration.
Top 10 Gainers:
- Tango Therapeutics Inc. (TNGX:NASDAQ), 103.92%
- Renovaro Biosciences Inc. (RENB:NASDAQ), 82.35%
- Decibel Therapeutics Inc. (DBTX:NASDAQ), 80.29%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 65.8%
- Science 37 Holdings Inc. (SNCE:NASDAQ), 53.24%
- Kubient Inc. (KBNT:NASDAQ), 44.37%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 42.5%
- Poseida Therapeutics Inc. (PSTX:NASDAQ), 37.88%
- Esports Technologies Inc. (EBET:NASDAQ), 37.5%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 34.89%